LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 1,526 - 1,550 of 2,688 « 1 … 60 61 62 63 64 … 108 » Adjuvant/Neo-adjuvant Systemic Therapy By: Heather Wakelee, MD View PDF Locally Advanced NSCLC (Neoadjuvant/Adjuvant Therapies) By: Heather Wakelee, MD View Video Adjuvant / Neo-adjuvant Systemic Therapy By: Heather Wakelee, MD, FASCO View PDF Adjuvant / Neo-adjuvant Systemic Therapy By: Heather Wakelee, MD, FASCO View Video Adjuvant/Neo-adjuvant Systemic Therapy By: Heather Wakelee, MD, FASCO View PDF Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether toPermanently Stop or Not By: Helen Shih View PDF Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether to Permanently Stop or Not By: Helen Shih View Video Efforts to Overcome Resistance to First Line Immunotherapy By: Hossein Borghaei, DO, MS View PDF ADC in NSCLC: TROP2 and HER3 in NSCLC By: Hossein Borghaei, MD View PDF ADC in NSCLC: TROP2 and HER3 in NSCLC By: Hossein Borghaei, MD View Video How to Choose Front- Line Therapy for Metastatic NSCLC Without Driver Mutations By: How to Choose Front- Line Therapy for Metastatic NSCLC Without Driver Mutations View PDF Lung Adenocarcinoma Updates By: Howard (Jack) West, MD View PDF Novel Treatment Strategies for Stage III NSCLC Beyond PACIFIC By: Howard (Jack) West, MD View Video Novel Treatment Strategies for Stage III NSCLC Beyond PACIFIC By: Howard (Jack) West, MD View PDF Roundtable Discussion By: Howard (Jack) West, MD & Sandip Patel, MD View PDF ALK: Choosing 1L & Mechanism of Resistance By: Ibiayi Dagogo-Jack, MD View PDF ALK: Choosing 1L & Mechanism of Resistance By: Ibiayi Dagogo-Jack, MD View Video Developmental Therapeutics and Novel Agents By: Ignacio Gil-Bazo, MD View Video Challenges in Lung Cancer Pathology: Biomarkers By: Ignacio Wistuba, MD View PDF Challenges in Lung Cancer Pathology: Biomarkers By: Ignacio Wistuba, MD View Video Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care By: J. Marie Suga, MD View PDF Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care By: J. Marie Suga, MD View Video EGFR & ALK: Where are We Now? By: Jacob Sands, MD View PDF ALK-Altered Non-Squamous NSCLC: Options and Sequence By: Jacob Sands, MD View Video EGFR & ALK: Where Are We Now? By: Jacob Sands, MD View Video
